DAX+0,19 % EUR/USD-0,35 % Gold-0,28 % Öl (Brent)+0,24 %

RavenQuest Sofa (Seite 29)



Begriffe und/oder Benutzer

 

Ich bin auch bei Minus - 25 %!.Mein Motto Augen zu und durch Sekt oder Selters!.Kaufe bei 0,30Euro noch einmal zu.
Glaubt ihr echt das das ganze noch auf 30cent runter geht ? Habe leider schon nach gekauft -.- hätte nach diesen Nachrichten eher auf ne stabile bzw leicht steigende Kursentwicklung getippt... aber mal abwarten ✌🏼
Moin,

Leute schaut nicht jeden Tag auf den Kurs.Das macht euch nur irre und bringt nix.Jeder weiß wie das Unternehmen aufgestellt ist und jetzt warten wir einfach auf die Lizenz und dann schauen wir weiter.
Und wenn,wie aktuell,der Gesammtmarkt negativ gestimmt ist,dann steigt auch keine RQB im Kurs.

bs
The Largest Cannabis Store in the World Opens in Las Vegas (12/11/2018) - What happens in Vegas, stays in Vegas? Not so, if the recently opened recreational cannabis megastore is anything to go buy. Las Vegas has always been known for setting the bar when it comes to giving people a good time, but the level to which “Planet 13” has taken cannabis will send waves around the world due to its massive size and opulence. Nevada State Senator Tick Segerblom summarized it well in his opening remarks when he said, “Welcome to Amsterdam on steroids!” Amsterdam, the Dutch capital, has previously held the record for being the best destination for those who want to consume recreational cannabis. Now Planet 13 has bested the entire Amsterdam, and some. All in one swell swoop, reports CNBC;
Acreage Holdings (15/11/2018) - The cannabis startup backed by former Speaker of the House John Boehner is set to become one of the most valuable companies in the U.S. weed industry. Acreage Holdings is the latest U.S. cannabis firm to tap the public markets in Canada, where marijuana is legal, through a reverse takeover. The company raised $314 million in a private placement that values it at about $2.8 billion. Acreage shares are set to start public trading on Thursday. Run by former Wall Street banker Kevin Murphy, Acreage has more has more than 40 dispensaries across the U.S. In addition to Boehner, a Republican, the company also counts former conservative Canadian Primer Minister Brian Mulroney as an adviser, reports Bloomberg;
http://www.businesselitecanada.com/emag/nov-2018/files/assets/basic-html/index.html#26

Artikel über RQB
https://microcap.com/p/cannabis?fbclid=IwAR1Ds5JmxJSgD6oGKRDUsWLBwHKwnSO-gwXfa3aXMSTDFgI23JFEuddmI28

Bewertungstabelle für kanadische Cannabisfirmen
"United States

U.S. lawsuit puts cannabis claims to the test. New Jersey moves closer to becoming the 11th U.S. state to legalize recreational Marijuana Use as the state heads to final vote by lawmakers. Battelle and Canopy Growth Corporation announced the completion of multiple fully legal cannabis imports from Canada to the United States.

Canada

Newlyformed Canadian group, Common Initiative, urges Canadian Government to allow medicinal marijuana to be sold in pharmacies and cuts to medical marijuana tax. Canadian marijuana companies accelerate medical marijuana use with CannTrust to determine the efficacy of CBD oil capsules in slowing the disease progression in patients with Amyotrophic Lateral Sclerosis and Motor Neuron Disease. The lack of local qualified labour in Canada has seen Aphria Inc import 50 workers from abroad.

Australia

The ACT is one step closer to legalisation of recreation cannabis use, with overwhelming support for bill for adults to keep 50g of cannabis for recreational use. Australian listed Cannabis companies meddles with Canada, with Creso Pharma to dual list on the Toronto Exchange and MGC to sell its MGC Subsidary to CannaGlobal Canada Co Inc. Zelda Therapeutics announced that it is to start human trials to replace use of opioid pain management therapy with cannabinoid medications.

World Cannabis News

27/11/2018 New Jersey Marijuana Legalization Heading to Final Vote by Lawmakers - New Jersey moved closer to becoming the 11th U.S. state to legalize recreational marijuana use after legislative committees approved bills to end the prohibition and wipe out the criminal records of some drug offenders. The action puts the bills on track for all-but-certain passage by the Assembly and Senate on Dec. 17. While Governor Phil Murphy, a Democrat, campaigned in part on easing marijuana laws, he has criticized the legislation’s tax rate of 14 percent, which would be among the lowest in the U.S., making it unclear whether he will sign the bills or send them back to lawmakers with suggested changes. The bills received approvals Monday by a joint hearing of the Senate and Assembly budget and appropriations panels in Trenton. The Senators voted 7-4, with two abstaining, and the Assembly members, 7-3, with one abstention, reports Bloomberg;
27/11/2018 Wannabe Weed ETF Has Bigger Challenge Than Pot Stocks' 30% Slump - A new exchange-traded fund is looking to make the case to buy pot stocks again after indexes tracking cannabis plunged more than 30 percent in less than two months. But that may not be its biggest hurdle. Investment firm OBP Capital of Rocky Mount, North Carolina, is seeking regulatory approval from the U.S. Securities and Exchange Commission to start the Innovation Shares Cannabis ETF, regulatory filings show. The fund, which will primarily invest in U.S. and Canadian companies linked to legal weed, shares a name with its index provider -- Innovation Shares LLC -- which backed blockchain and autonomous vehicles funds earlier this year. U.S. banks, which are federally regulated, have been reluctant to engage with an industry that’s illegal under national law. However, these are the institutions that ETFs typically rely on to serve as custodians for their holdings. OBP Capital’s filing doesn’t currently list a custodian for the fund, reports Bloomberg;
26/11/2018 Bill to legalise recreational marijuana in ACT has ‘overwhelming support’ - A major push to legalise recreational marijuana has been launched in the ACT where a young Labor pollie claims he has overwhelming support for his bill on the issue. If it gets enough support it would allow adults in the state to keep up to 50g of cannabis or four plants legally. ACT backbencher Michael Pettersson said 94 per cent of people or groups that responded to his invitation to make a submission were in support of the proposal. The intent of the bill has even received backing from the Alcohol Tobacco and Other Drug Association ACT, the peak body for alcohol, tobacco and other drug sector. “This polling shows that Canberrans are overwhelmingly in favour of sensible changes to our drug laws like legalising small amounts of cannabis for personal use,” Mr Pettersson told the Times. “Cannabis legalisation is not a radical idea. There are now 10 states in the United States of America that have legalised cannabis along with Canada, South Africa and Uruguay. “I don’t think anyone should have their life ruined with a criminal conviction for using small amounts of cannabis, reports news.com.au;
27/11/2018 How Cannabis Could Become The Next Real Estate Disrupter - For a while it looked like the best thing to bring to a neighborhood was a new Whole Foods grocery store. One study showed that homes in these neighborhoods would appreciate at a much faster rate than if they were near a Trader Joe's (and both were better than a Starbucks). Another sign a neighborhood is on the cusp of revitalization is when the yoga studios start vying for space with the arthouses. Usually it is not long after that the expensive coffee shops and cupcake stores start showing up at street level. But now that so many states have passed laws favorable to the marijuana movement, the next big thing to bring a neighborhood back from the brink just might be the increasing number of organizations that work in the industry. Downtown Los Angeles could be the first case study to see this phenomenon in action. Next month, a seven-story building in the heart of Los Angeles' Jewelry District will open up, filled with tenants who all have cannabis somewhere in their job description. Real estate investment company Bow West Capital purchased the property last year for a reported $14 million. Once open it will be the largest real estate space dedicated to cannabis in the U.S, reports Forbes;
29/11/2018 Patents on pot? U.S. lawsuit puts cannabis claims to the test - In October, the U.S. government issued Axim Biotechnologies Inc a patent for a cannabis-based suppository to treat irritable bowel syndrome. Britain’s GW Pharmaceuticals Plc, which recently brought to market a drug derived from marijuana for epilepsy, is now seeking patent protection for another one to treat eczema. With marijuana now fully legal in Canada and at least partially legalized in the majority of U.S. states, companies are rushing to patent new formulations of the age-old botanical. This year, the U.S. Patent and Trademark Office has issued 39 patents containing the words cannabis or marijuana in their summaries, up from 29 in 2017 and 14 in 2016, reports Reuters;
28/11/2018 Medicine or vice? Socially screened funds struggle to define cannabis industry - Is marijuana a medicine or a vice? The $8 trillion U.S. socially responsible investment industry is grappling with that question as more states approve the recreational use of cannabis, pushing consumption closer to “sin” stocks like alcohol and tobacco that ethically focused investors avoid. Ten U.S. states and the District of Columbia have legalized the recreational use of marijuana for adults over the age of 21, and New Jersey lawmakers on Monday proposed legalizing it. No U.S. public companies are directly selling marijuana, but Canadian marijuana producers like Tilray Inc and Canopy Growth Corp are on U.S. exchanges. In mid-October Canada legalized recreational cannabis and that is leading fund managers and their clients to decide if they feel comfortable investing in marijuana if it is not for medicinal use. Marijuana is used to treat a range of conditions from epilepsy to migraines, reports Reuters;
28/11/2018 Proposed hemp regulations continue the racist legacy of the US war on drugs - Until recently, hemp—the name for a cannabis plant bred to have little to no THC (tetrahydrocannabinol)—has been far less exciting in the popular imagination than its psychotropic sister, marijuana. But CBD (cannabidiol), the naturally occurring chemical compound found in both cannabis and hemp, has caught fire (so to speak) in the wellness world. This has made hemp a hot commodity. Industry analysts at the Brightfield Group estimate that the US market for hemp-derived CBD in the form of tinctures, capsules, vaporizers, pet treats, and more will be worth $591 million in 2018, reports Quartz;
27/11/2018 Wannabe Weed ETF Has Bigger Challenge Than Pot Stocks' 30% Slump - A new exchange-traded fund is looking to make the case to buy pot stocks again after indexes tracking cannabis plunged more than 30 percent in less than two months. But that may not be its biggest hurdle. Investment firm OBP Capital of Rocky Mount, North Carolina, is seeking regulatory approval from the U.S. Securities and Exchange Commission to start the Innovation Shares Cannabis ETF, regulatory filings show. The fund, which will primarily invest in U.S. and Canadian companies linked to legal weed, shares a name with its index provider -- Innovation Shares LLC -- which backed blockchain and autonomous vehicles funds earlier this year, reports Bloomberg;
29/11/2018 Make Medical Pot Available at Pharmacies, Canada Group Urges - Canadian governments should allow medical marijuana to be sold in pharmacies, according to a newly formed group of pot producers, drug companies, pharmacists and retailers. Dubbed the Common Initiative, the group is urging changes to Canada’s medical marijuana regulations, which only allow for distribution of the drug via mail. It’s also pushing for tax on medical pot to be dropped so it’s treated the same as other medicines. The move to allow easier access would reduce the risk of patients self-medicating through the recreational market, the group argues. It may also help boost sales. “The pharmacist is the best health-care professional and has your entire medical profile,” said Michel Robidoux, president and general manager of Sandoz Canada, a division of Swiss pharmaceutical giant Novartis AG. “If you use medical cannabis under a doctor’s recommendation, there should be visibility by your pharmacist.”, reports Bloomberg."
 Durchsuchen


Beitrag zu dieser Diskussion schreiben